Abstract
This study reports the use of chitosan microcapsules for daunorubicin delivery via an oral route. The potential oral delivery of the daunorubicin/chitosan microcapsules was examined using an in vivo athymic nude mice xenograft model with Non-Hodgkin's lymphoma cells. Microencapsulated daunorubicin could be administered orally with tumour growth inhibition activity.
Original language | English |
---|---|
Pages (from-to) | 14109-14114 |
Number of pages | 6 |
Journal | RSC Advances |
Volume | 4 |
Issue number | 27 |
DOIs | |
Publication status | Published - 2014 |
Scopus Subject Areas
- Chemistry(all)
- Chemical Engineering(all)